Table 3.
Multivariate model for prediction of coronary artery disease in patients with fatty liver.
| OR * | ±95% CI | p | |
|---|---|---|---|
| Fatty Liver (L-S density < −10 HU) | 2.5 | 1–4.0 | 0.001 |
| IMT (>0.80 mm) | 2.3 | 0.9–3 | 0.001 |
| Retinal AVR (>0.7) | 1.5 | 0.5–1.5 | 0.01 |
| HOMA (>3.0) | 0.8 | 0.5–1.5 | 0.08 |
| CRP (>0.5 mg/dL) | 0.7 | 0.5–0.9 | 0.4 |
| Metabolic syndrome (present/absent) | 1.2 | 0.9–3.5 | 0.03 |
* Odds ratios (OR) are adjusted for gender, age, smoking habits, metabolic syndrome, diabetes, BMI, and levels of ALT, HDL and LDL-cholesterol, triglycerides, and fasting glucose.